Injection drug use represents the primary risk factor for up to 40% of pati
ents with HIV infection. Physicians are generally reluctant to prescribe an
tiretroviral therapy (ART) for these patients due to possible poor adherenc
e, and the potential for complex drug interactions to occur. Providing dail
y observed ART in conjunction with methadone maintenance therapy (MMT) has
significantly improved accessibility of ART for many drug users. Knowledge
of potential drug interactions between methadone, ART, and both legally and
illegally prescribed drugs has permitted such interactions to be anticipat
ed and either avoided or treated appropriately. Optimizing ART for drug use
rs therefore demands a multidisciplinary approach from medical, clinical ph
armacology and psychiatric services.